Pictured: Dr. Dermot Kelleher (front, left) and Dr. Jianping Fan (front, right) sign a memorandum of understanding at DMCBH on June 13, 2019. Image credit: Paul Joseph/UBC.
Newsroom
For media enquiries or more information about research at the Djavad Mowafaghian Centre for Brain Health, please contact Emily Wight, Communications Manager.
- Email: emily.wight@brain.ubc.ca
- Phone: 604-417-0165
To keep in touch with the Centre and up-to-date on our research, follow us on Twitter or subscribe to Brain Matters, our monthly e-newsletter.
This week, the Government of Canada announced the next phase of funding for the Canadian Consortium on Neurodegeneration in Aging (CCNA). From 2019 to 2024, CCNA will receive $46 million from the Canadian Institutes of Health Research (CIHR) and 11 other partner organizations.
Djavad Mowafaghian Centre for Brain Health (DMCBH) researchers have received a $540,000 investment from CCNA; there are 13 CCNA-affiliated researchers at DMCBH, five of whom have leadership roles, highlighting the centre’s depth of expertise in dementia:
British Columbians returning to work after a concussion now have access to new online resources and courses that help them navigate their injury and offer guidance for a safe return to work.
Pictured: Dr. Anthony Trabouslee. Image credit: Paul Joseph/UBC.
In 2031, nearly one in four Canadians will be aged 65 or older. As Canada’s population ages, it will be important to establish evidence-based, inexpensive, non-pharmaceutical interventions to slow the effects of aging on cognition and mobility. New research from Lisanne ten Brinke, a PhD candidate in Dr.
Pictured: Dr. Carles Vilariño-Güell in his laboratory at the Djavad Mowafaghian Centre for Brain Health. Image credit: Paul Joseph/UBC.
An international team of researchers led by investigators at the Djavad Mowafaghian Centre for Brain Health at the University of British Columbia has made a scientific advance they hope will lead to the development of preventative treatments for multiple sclerosis (MS).
Pictured: Dr. Teresa Liu-Ambrose in her lab at the Djavad Mowafaghian Centre for Brain Health.
Pictured: Dr. Bernier discusses microglia morphology with Dr. Nick Weilinger, a postdoctoral fellow in Dr. Brian MacVicar's lab. Image credit: Paul Joseph/UBC.
Written by Daniela Salas from the Foster lab, Michael Smith Laboratories and cross-posted to centreforbrainhealth.ca.
Autism spectrum disorder (ASD) is a mental disorder affecting the development of the nervous system, characterized by deficits in social communication and repetitive behaviours. This condition manifests in early childhood and lasts a person's entire lifetime, and the most important risk factor is genetic.
Research from Dr. Teresa Liu-Ambrose and colleagues has informed the new WHO guidelines for risk reduction of cognitive decline and dementia. Read the guidelines at who.int. Related: WHO issues first advice on dementia: exercise and don't smoke (REUTERS).
